001     281831
005     20251113125814.0
024 7 _ |a 10.1186/s42466-025-00433-9
|2 doi
024 7 _ |a pmid:41146293
|2 pmid
024 7 _ |a pmc:PMC12560544
|2 pmc
037 _ _ |a DZNE-2025-01212
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Reetz, Kathrin
|0 0000-0002-9730-9228
|b 0
245 _ _ |a The German Dementia Registry (DEMREG): study protocol of a biomarker-based national registry for cognitive impairment and dementia.
260 _ _ |a [London]
|c 2025
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1763034980_32674
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The German Dementia Registry (DEMREG) is a large-scale national prospective biomarker-based study for cognitive impairment and dementia, providing an integrated clinical research platform for research studies.The DEMREG study longitudinally collects demographic, clinical, genetic, biological, and imaging data, along with risk factors and treatment information from real-world settings. Comprehensive clinical assessments are conducted yearly. This extensive resource enables researchers to investigate current diagnostic and treatment practices and explore the complex relationships between risk factors and outcomes. The registry is now active across 22 sites in Germany, all members of the the German Memory Clinic Network (DNG), with more than 500 patients recruited to date, and is expected to include up to 1.000 patients annually.The DEMREG study represents a large nationally harmonized cohort of detailed real-world clinical and biological data from patients with cognitive impairment and dementia, enabling insights into long-term dynamics and treatment responses. This infrastructure has the potential to foster collaborative research and roll out healthcare innovations across different settings in Germany. In this context, a substudy will soon be conducted to evaluate long-term safety and efficacy measures of the new monoclonal antibodies targeting amyloid plaques in a clinical setting.The protocol is registered at German Clinical Trials Register (DRKS00027547), Date of Registration: 01.04.2022.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Biomarkers
|2 Other
650 _ 7 |a Dementia
|2 Other
650 _ 7 |a Mild cognitive impairment
|2 Other
650 _ 7 |a Natural history
|2 Other
650 _ 7 |a Neurodegeneration
|2 Other
650 _ 7 |a Registry
|2 Other
650 _ 7 |a Treatment
|2 Other
700 1 _ |a Costa, Ana Sofia
|b 1
700 1 _ |a Michels, Jennifer
|b 2
700 1 _ |a Albrecht, Milena
|b 3
700 1 _ |a Moschko, Pia
|b 4
700 1 _ |a Pahl, Jennifer
|b 5
700 1 _ |a Häger, Alexa
|b 6
700 1 _ |a Schuckelt, Rainer
|b 7
700 1 _ |a Röhrig, Rainer
|b 8
700 1 _ |a Wienströer, Jan
|b 9
700 1 _ |a Flöel, Agnes
|0 P:(DE-2719)2812683
|b 10
|u dzne
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 11
|u dzne
700 1 _ |a Onur, Oezguer A
|b 12
700 1 _ |a Grimmer, Timo
|b 13
700 1 _ |a Levin, Johannes
|0 P:(DE-2719)2811659
|b 14
|u dzne
700 1 _ |a Frölich, Lutz
|b 15
700 1 _ |a Jessen, Frank
|0 P:(DE-2719)2000032
|b 16
|u dzne
700 1 _ |a Schulz, Jörg B
|b 17
700 1 _ |a Registry, German Dementia
|b 18
|e Collaboration Author
700 1 _ |a Polivka, Dörte
|b 19
|e Contributor
700 1 _ |a Duning, Thomas
|b 20
|e Contributor
700 1 _ |a Gutschalk, Alexander
|b 21
|e Contributor
700 1 _ |a Oberstein, Timo
|b 22
|e Contributor
700 1 _ |a Schnieder, Marlena
|b 23
|e Contributor
700 1 _ |a Trender-Gerhard, Iris
|b 24
|e Contributor
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 25
|e Contributor
|u dzne
700 1 _ |a Dahling, Volker
|b 26
|e Contributor
700 1 _ |a Peters, Oliver
|0 P:(DE-2719)2811024
|b 27
|e Contributor
|u dzne
700 1 _ |a Saur, Dorothee
|b 28
|e Contributor
700 1 _ |a Spruth, Eike Jakob
|0 P:(DE-2719)2812446
|b 29
|e Contributor
|u dzne
700 1 _ |a Cheng, Bastian
|b 30
|e Contributor
700 1 _ |a Fußer, Fabian
|b 31
|e Contributor
700 1 _ |a Bartsch, Thorsten
|b 32
|e Contributor
700 1 _ |a Glanz, Wenzel
|0 P:(DE-2719)2811614
|b 33
|e Contributor
|u dzne
700 1 _ |a Hausner, Lucrezia
|b 34
|e Contributor
700 1 _ |a Riemenschneider, Matthias
|b 35
|e Contributor
700 1 _ |a Höltje, Esther
|b 36
|e Contributor
700 1 _ |a Hellmann-Regen, Julian David Nicolai
|0 P:(DE-2719)9003016
|b 37
|e Contributor
|u dzne
773 _ _ |a 10.1186/s42466-025-00433-9
|g Vol. 7, no. 1, p. 80
|0 PERI:(DE-600)2947493-0
|n 1
|p 80
|t Neurological research and practice
|v 7
|y 2025
|x 2524-3489
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/281831/files/DZNE-2025-01212.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/281831/files/DZNE-2025-01212.pdf?subformat=pdfa
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2812683
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2000005
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2811659
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2000032
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 25
|6 P:(DE-2719)2000055
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 27
|6 P:(DE-2719)2811024
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 29
|6 P:(DE-2719)2812446
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 33
|6 P:(DE-2719)2811614
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 37
|6 P:(DE-2719)9003016
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-30
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:42:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:42:53Z
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-30
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:42:53Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-30
920 1 _ |0 I:(DE-2719)5000081
|k AG Flöel
|l Dementia Prevention – Mechanisms and Clinical Implementation
|x 0
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 1
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 2
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Clinical Alzheimer’s Disease Research
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000081
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a I:(DE-2719)1011102
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21